monarche results: abemaciclib plus endocrine therapy in high-risk early breast cancer
Published 3 years ago • 3.7K plays • Length 4:19Download video MP4
Download video MP3
Similar videos
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
1:08
4-year monarche results: increasing benefits with abemaciclib et for er /her2- high-risk early bc
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
1:04
5-year monarche results: abemaciclib et in high-risk ebc
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
8:39
final overall survival analysis of monarch 1
-
1:59
monarche: patient-reported outcomes
-
1:26
monarche: investigating adjuvant abemacicilib for high-risk hr breast cancer
-
8:55
abemaciclib with endocrine therapy in the treatment of high-risk early breast cancer: asco optima...
-
4:45
monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer
-
4:11
ribociclib plus endocrine therapy improves survival in premenopausal patients with metastatic br...
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
3:06
age-stratified findings from the monarche trial of abemaciclib in breast cancer
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy